Wedbush Cuts Solid Biosciences (NASDAQ:SLDB) Price Target to $17.00
Solid Biosciences (NASDAQ:SLDB – Get Free Report) had its price objective decreased by investment analysts at Wedbush from $18.00 to $17.00 in a report released on Friday,Benzinga reports. The firm currently has an “outperform” rating on the stock. A number of other equities analysts have also weighed in on SLDB. HC Wainwright boosted their price […]
